Every escalation step
Based on the findings, the researchers suggest that semaglutide lowers body weight by directly interacting with diverse GLP-1R populations and directly and indirectly affecting the activity of neural pathways involved in food intake, reward, and energy expenditure
According to the FDA, the benefits still far outweigh the risks for some of the people who take the medication
This agent may lead to earlier initiation of GLP-1RA therapy in the type 2 diabetes continuum of care, and represents a valuable treatment option for patients with a preference for oral therapy
Given its benefits for cardiovascular health, Semaglutide is also suitable for individuals with type 2 diabetes who are at high risk for cardiovascular events
For some patients, this disruption manifests as diarrhea, while others may experience alternating constipation